Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three abstracts highlighting significant advancements in the development of a ...
Exact Sciences reported third-quarter results that fell short of analyst expectations and cut its guidance for the fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback